In the meantime, their plan involves continuing R& D, building a commercial prototype and seeking FDA approval by 2013.Cellulosic Biotherapeutics: For 5 million people in the U. The only treatment option is painkillers, and many people eventually undergo spinal surgery. The Cellulosic team, which received funding from the National Science Foundation, plans to finish the R& D and proof of concept phases by 2012 and clinical trials by 2018, at which time there would be a partnership opportunity with a major medical device company. Cortical Concepts: To stabilize segments of the spine during back surgery, doctors insert rods and screws to hold the spine in place until it heals, which can take six to nine months.
Over the year, the entries are whittled down until eight finalists remain to compete for the grand prize at the Venture Finals.
The judges at the Venture Finals this year included representatives from Co Active Health Solutions, Karlin Asset Management, Trevena, First Round Capital and .
First Stage Diagnostics: Team member Manish Maheshwari asked the audience members to think about the four most important women in their lives.
Chances are, he said, that one of them has dense breast tissue and a 50% chance of having a tumor missed on a mammogram.
With a prototype already developed, the group intends to start a pilot study this year. According to Nuttall, Power Water will be positioned as a healthy alternative to juices and soft drinks offered by the large multinational companies.
Hector Beverages LLC: Priced at just 18¢, Hector's Power Water is currently sold at the lowest price among branded beverages in India and is the only widely available health-oriented drink in that market, said team leader James Nuttall, a second-year Wharton M. With the beverage market in India worth .2 billion and annual sales growth of 30%-40%, Nuttall expects Hector's revenue to exceed 0 million within its first five years.The ideas included a cervical cancer screening device, an antibiotic to treat infections caused by drug-resistant bacteria, a private sales club for students and a healthy beverage for bottom of the pyramid markets.Competing for more than ,000 in combined prizes and in-kind legal/accounting services, the finalists presented their plans recently to five judges and an audience of venture capitalists, business leaders, faculty and students.According to team leader Greg Millhauser, a second-year Wharton M. He explained that CADIA's Cervi Probe offered a better alternative, as it uses a probe to immediately diagnose cancer with more sensitivity than the Pap test.Although the probe can be used on any mucous membrane in the body, the team chose to focus on its use for cervical screening based on the size of the market opportunity. S., more than 50 million women receive Pap tests every year.As for competitors, Nuttall told the judges that when he approached large multinationals with this concept, they were interested but not prepared to be the first mover. college students who spend over 0 billion annually, particularly on brands they perceive as elevating their social status, students usually have a limited budget.So he expects larger beverage companies to come "knocking on his door" after the business is more established. This presents a problem for producers of consumer goods because it's difficult to build loyalty and give students the prices they want without diluting company brands. student Aymeric de Hemptinne, is Kembrel.com, an invitation-only online private sales club for college students.The device expands as the screw is inserted into the bone, negating the presence of osteoporosis conditions.Cortical Concepts says the market for the device is 720,000 units or 0 million a year.More than 230 teams entered the competition compared to 162 last year and 145 the year before.More than 250 judges were involved in the various phases of the competition, which begins in the fall with the initial submission of students' business concepts.